Epidemiology


  • Most common benign lesion of the breast
  • Usually occurs in pre-menopausal women, likely hormone mediated

Etiology


Pathophysiology


  • Benign, non-cancerous changes in breast tissue related to an exaggerated response to ovarian hormones (estrogen and progesterone). It is the most common breast lesion.
  • Characterized by a combination of fibrosis (thickening of stromal tissue), adenosis (proliferation of glandular tissue), and cyst formation.
  • Symptoms typically fluctuate with the menstrual cycle, worsening in the premenstrual (luteal) phase.

Clinical features


  • Demographics: Most common in premenopausal women, typically between ages 20 and 50. Symptoms usually subside after menopause unless a woman is on hormone replacement therapy.
  • Symptoms: Cyclical, bilateral breast pain (mastalgia) or tenderness, especially in the upper outer quadrants.
  • Physical Exam: Palpable lumps or “lumpiness” that may feel rubbery, rope-like, or nodular. Masses are often multiple, mobile, and may fluctuate in size with the menstrual cycle. A serous, non-bloody nipple discharge can occur.

Subtypes and variants


  • Apocrine metaplasia
    • No risk
    • A-Okay
  • Sclerosing adenosis
    • Some risk
    • Sclerosing = Some
  • Atypical hyperplasia
    • Significant risk
    • Atypical likely to Aturn into cancer

Diagnostics



Differential diagnostics

  • Fibroadenoma: Typically a single, well-circumscribed, firm, rubbery, non-tender, and highly mobile mass. More common in younger women (<35).
  • Breast Cancer: Usually a single, hard, non-tender, immobile mass with irregular borders. May be associated with skin dimpling, nipple retraction, or bloody discharge.
  • Fat Necrosis: Often related to a history of breast trauma; may present as a firm, irregular mass, sometimes with skin retraction or calcifications on mammogram that can mimic cancer.
  • Mastitis: Presents with signs of infection like fever, erythema, and warmth, often in lactating women.

Treatment